Your browser doesn't support javascript.
loading
[Justification to health managers: cost-benefit of osteoporosis management]. / Justificación delante del gerente: coste-beneficio del manejo de la osteoporosis.
Hernández-García, César.
Afiliação
  • Hernández-García C; Subdirección General de Medicamentos de Uso Humano, Agencia Española de Medicamentos y Productos Sanitarios, Madrid, España. chernandezg@aemps.es
Reumatol Clin ; 7 Suppl 2: S13-7, 2011 Sep.
Article em Es | MEDLINE | ID: mdl-21924214
Medicines are strictly regulated and controlled until they reach the patients. Once in the market, the mechanisms governing their use are very complex due to the large number of actors playing different roles. It is necessary to extend an evaluation culture among all involved and to make economic analysis a structured part of decisions made by physicians and health managers. Since physicians occupy a central place in this market of medicines, it is necessary that they assume their responsibility by actively participating in this evaluation.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Osteoporose / Assistência Farmacêutica Tipo de estudo: Health_economic_evaluation Limite: Humans Idioma: Es Revista: Reumatol Clin Ano de publicação: 2011 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Osteoporose / Assistência Farmacêutica Tipo de estudo: Health_economic_evaluation Limite: Humans Idioma: Es Revista: Reumatol Clin Ano de publicação: 2011 Tipo de documento: Article